glp 1 agonist hypothyroidism Can a patient with unstable and hypercholesterolemia, taking pravastatin and ezetimibe, start a GLP-1 (Glucagon-Like Peptide-1) receptor for weight loss? GLP-1 Agonists: The Medical Revolution
Description
1999;276(6 Pt 1):E1049E1054
Benefits of GLP-1 program Who Is a GLP-1 program Suitable For
Back Lund, PK, Goodman, RH, Jacobs, JW, Habener, JF (July 1980) 'Glucagon precursors identified by immunoprecipitation of products of cell-free translation of messenger RNA', Diabetes , 29, 583-86
GLP-1 therapies reduced inflammatory markers and protected kidney function in animals and humans, including in the FLOW trial
The NEJM authors reported the most common side effects as mild-to-moderate gastrointestinal events, with the trial discontinued due to adverse events in 4.4% to 7.8% of participants receiving orforglipron compared to 1.4% given the placebo
